Akebia Therapeutics, Inc.’s AKBA share price has surged by 11.37%, which has investors questioning if this is right time to ...

Anemia is a common condition in premature infants, particularly those at risk for retinopathy of prematurity (ROP). While the ...

Despite finally winning a hard-fought FDA approval for its chronic kidney disease (CKD) anemia drug Vafseo last year, Akebia ...

1Molecular and Cell Biology Laboratory, Salk Institute for Biological Studies, La Jolla, California.

This summary highlights only some of the key features and terms of the actual license. It is not a license and has no legal value. Carefully review the actual license before using these materials.

an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease ...

1Ben Towne Center for Childhood Cancer and Blood Disorders Research, Seattle Children’s Research Institute, Seattle, Washington. 2The Department of Pediatrics, Seattle Children’s Hospital, Fred ...

Andrea Lius is a freelance science writer. She is working on her PhD in pharmacology at the University of Washington in Seattle. View Full Profile. Learn about our Editorial Policies. Since then, many ...

Hepatitis B virus (HBV) is an important but difficult to study human pathogen. Most basics of the hepadnaviral life-cycle were unraveled using duck HBV (DHBV) as a model although DHBV has a capsid ...